Latest Articles
What If We Took Endometriosis as Seriously as We Take Diabetes? - Women's eNews
What If We Took Endometriosis as Seriously as We Take Diabetes? Women's eNews
Published: Oct. 20, 2025, 6:42 p.m.
Celebrities That Have Endometriosis: Halsey, Barbara Palvin, More - Life & Style
Celebrities That Have Endometriosis: Halsey, Barbara Palvin, More Life & Style
Published: Oct. 20, 2025, 6:05 p.m.
Why Is Genmab Stock Trading Lower On Monday? - inkl
Why Is Genmab Stock Trading Lower On Monday? inkl
Published: Oct. 20, 2025, 3:57 p.m.
Waiting times for endometriosis care 'a catastrophe' says Lothian MP - Edinburgh News
Waiting times for endometriosis care 'a catastrophe' says Lothian MP Edinburgh News
Published: Oct. 20, 2025, 3:57 p.m.
Ibuprofen: How An Everyday Drug Might Offer Protection Against Cancer - Study Finds
Ibuprofen: How An Everyday Drug Might Offer Protection Against Cancer Study Finds
Published: Oct. 20, 2025, 3:54 p.m.
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer - Pulse 2.0
Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer Pulse 2.0
Published: Oct. 20, 2025, 3:54 p.m.
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in E - PharmiWeb.com
Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in E PharmiWeb.com
Published: Oct. 20, 2025, 3:02 p.m.
Bella Hadid says ‘it’s hard to take a shower most days’ and is ‘excruciating pain’ due to Lyme disease condition - AOL.com
Bella Hadid says ‘it’s hard to take a shower most days’ and is ‘excruciating pain’ due to Lyme disease condition AOL.com
Published: Oct. 20, 2025, 2:55 p.m.
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma - Barchart.com
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma Barchart.com
Published: Oct. 20, 2025, 2:34 p.m.
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider
Published: Oct. 20, 2025, 2:27 p.m.
Link copied to clipboard!